StockData
Shoulder Innovations, Inc. logo

Shoulder Innovations, Inc. (SI) shareholders

SINYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3051% above fair value
$20.56+0.11 (+0.54%)

Close on Nov 17, 2026Market cap $428.04MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
39.8%
8M of 21M shares
Institutional holders
72
24 new, 9 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
7 buys · 17 sales
Net sold $5.25M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
FMR LLC
Joint filing with Abigail P. Johnson (19.00%)
3,848,79119.00%13G (passive)Aug 29, 2025
Abigail P. Johnson
Joint filing with FMR LLC (17.70%)
3,673,96017.70%13G (passive) amendmentJun 30, 2026
Casey M. Tansey
Joint filing with Presidio Management Group XII, L.L.C. (13.10%), U.S. Venture Partners XII, L.P. (8.20%)
2,740,78713.30%13G (passive)Sep 30, 2025
Martemanshurk B.V.
Joint filing with Gilde Healthcare Holding B.V. (10.70%), Gilde Healthcare V Management B.V. (10.70%) and 2 more
2,212,20710.70%13D (active) amendmentAug 5, 2026
Henry A. Plain Jr.
Joint filing with LSV Associates II, LLC (9.30%), Michael A Carusi (9.30%) and 2 more
1,885,1369.30%13G (passive)Sep 30, 2025
Churchill R. Sean
Joint filing with cultivate(MD) Holdings, LLC (6.70%), Blue David Lawrence (6.70%) and 2 more
1,363,3946.70%13G (passive)Sep 30, 2025
Arboretum Investment Manager VI, LLC
Joint filing with Arboretum Ventures VI, L.P. (5.80%), Jan L. Garfinkle (5.80%) and 2 more
1,163,8915.80%13G (passive)Aug 1, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of SIValueChange% of portfolio
FMR LLC3,673,96017.65%$74.51M−110,5920.00%
BlackRock, Inc.638,4203.07%$12.95M+82,3680.00%
Sectoral Asset Management Inc430,4072.07%$8.73M–6.09%
Vanguard Capital Management LLC392,1811.88%$7.95M−21,2990.00%
KCM Capital Inc300,0001.44%$6.08M+265,0000.98%
TimesSquare Capital Management, LLC298,2191.43%$6.05M−24,54588.95%
Roubaix Capital, LLC255,2881.23%$5.18M−1,8331.86%
Driehaus Capital Management LLC253,7601.22%$5.15MNew0.03%
Parkman Healthcare Partners LLC226,2121.09%$4.59MNew0.47%
Geode Capital Management, LLC199,5290.96%$4.05M+15,8500.00%
CM Management, LLC145,0000.70%$2.94M+45,0001.96%
JPMorgan Chase & Co124,4370.60%$2.62M−6,2740.00%
Morgan Stanley117,2650.56%$2.38M−40,3130.00%
State Street Corp114,8590.55%$2.33M+21,6140.00%
HighTower Advisors, LLC102,6400.49%$2.08MNew0.00%
Jane Street Group, LLC86,3070.41%$1.75MNew0.00%
Walleye Capital LLC86,1550.41%$1.75M+9720.01%
Schonfeld Strategic Advisors LLC77,7370.37%$1.58MNew0.01%
Northern Trust Corp71,2910.34%$1.45M+7,2240.00%
Vanguard Portfolio Management LLC70,3350.34%$1.43M+9,3380.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026728M39.8%24 / 3011 / 92M1M
Q1 2026588M36.6%16 / 249 / 72M0M
Q4 2025507M31.8%13 / 1216 / 51M1M
Q3 2025427M35.2%42 / 00 / 07M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

91 funds held SI in Q2 2026, 17% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of SIValue% of fundAs of
Select Medical Technology and Devices Portfolio947,7634.55%$13.93M0.47%May 31, 2026
Fidelity Small Cap Growth Fund777,6173.74%$17.68M0.20%Jul 31, 2026
Select Health Care Portfolio545,2862.62%$8.02M0.14%May 31, 2026
Fidelity Balanced Fund505,5722.43%$7.43M0.01%May 31, 2026
Fidelity Small Cap Growth K6 Fund387,9031.86%$8.82M0.19%Jul 31, 2026
Vanguard Total Stock Market Index Fund322,2311.55%$6.53M0.00%Jun 30, 2026
Fidelity Advisor Health Care Fund310,6921.49%$7.07M0.23%Jul 31, 2026
iShares Russell 2000 ETF264,6481.27%$5.37M0.01%Jun 30, 2026
Fidelity Small Cap Index Fund114,7000.55%$2.61M0.01%Jul 31, 2026
iShares Russell 2000 Value ETF87,8380.42%$1.78M0.01%Jun 30, 2026
JPMorgan Small Cap Value Fund76,7330.37%$1.56M0.12%Jun 30, 2026
VIP Balanced Portfolio68,6000.33%$1.39M0.02%Jun 30, 2026
AST Small-Cap Equity Portfolio66,8150.32%$1.36M0.06%Jun 30, 2026
Vanguard Extended Market Index Fund56,4180.27%$1.14M0.00%Jun 30, 2026
Vanguard Russell 2000 Index Fund53,2260.26%$782.42K0.00%May 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Robert Joseph BallCEO & Executive Chairman, Director417,9422.01%Nov 2, 2026
Matthew Fraser AhearnChief Operating Officer, Director245,7761.18%Aug 18, 2026
Jonathan E. OsborneChief Commercial Officer60,3550.29%Aug 10, 2026
Jeffrey S. PointsChief Financial Officer68,8350.33%Mar 17, 2026
David Lawrence BlueSee Remarks139,3720.67%Feb 3, 2026
Kevin K. SidowDirector25,9480.12%Oct 6, 2026
Casey M. TanseyDirector, 10% owner2,746,56413.19%Oct 6, 2026
Paul BuckmanDirector65,0250.31%Oct 6, 2026
Andrew HykesDirector7,4380.04%Oct 6, 2026
Richard BuchholzDirector18,7120.09%Jun 29, 2026
Michael A. CarusiDirector1,626,1367.81%Aug 5, 2025
Geoffrey B. PardoDirector, 10% owner2,288,14810.99%Aug 5, 2025
Healthcare Holding B.V. Gilde10% owner2,185,91410.50%Aug 28, 2026
Jean George–––Aug 5, 2025
LSV Associates II, LLC–––Aug 5, 2025
Lightstone Ventures II, L.P.–––Aug 5, 2025
Henry A. Plain JR–––Aug 5, 2025
Lightstone Ventures II (A), L.P.–1,885,1369.05%Aug 5, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Robert Joseph Ball
CEO & Executive Chairman, Director
Oct 30, 2026Tax withholding−29,639$20.44$605.82K417,942
Robert Joseph Ball
CEO & Executive Chairman, Director
Oct 30, 2026Option exercise+66,757$2.48$165.58K447,581
Kevin K. Sidow
Director
Oct 5, 2026Award+892$19.60$17.48K25,948
Andrew Hykes
Director
Oct 5, 2026Award+669$19.60$13.11K7,438
Casey M. Tansey
Director, 10% owner
Oct 5, 2026Award+733$19.60$14.37K53,445
Paul Buckman
Director
Oct 5, 2026Award+1,275$19.60$24.99K65,025
Robert Joseph Ball
CEO & Executive Chairman, Director
Sep 14, 2026Option exercise+89,233$2.10$187.39K390,999
Robert Joseph Ball
CEO & Executive Chairman, Director
Sep 14, 2026Sale−10,175$18.45$187.73K380,824
Healthcare Holding B.V. Gilde
10% owner
Aug 26, 2026Sale−1,196$22.60$27.03K2,185,914
Healthcare Holding B.V. Gilde
10% owner
Aug 24, 2026Sale−681$22.62$15.40K2,187,110
Healthcare Holding B.V. Gilde
10% owner
Aug 21, 2026Sale−20,516$22.61$463.87K2,187,791
Healthcare Holding B.V. Gilde
10% owner
Aug 20, 2026Sale−3,900$22.60$88.14K2,208,307
Matthew Fraser Ahearn
Chief Operating Officer, Director
Aug 18, 2026Sale(10b5-1 plan)−12,586$20.94$263.55K245,776
Matthew Fraser Ahearn
Chief Operating Officer, Director
Aug 18, 2026Sale(10b5-1 plan)−1,600$21.38$34.21K244,176
Matthew Fraser Ahearn
Chief Operating Officer, Director
Aug 17, 2026Sale(10b5-1 plan)−8,314$20.10$167.11K258,362
Matthew Fraser Ahearn
Chief Operating Officer, Director
Aug 14, 2026Gift−2,500––266,676
Healthcare Holding B.V. Gilde
10% owner
Aug 6, 2026Sale−2,095$22.60$47.35K2,212,207
Healthcare Holding B.V. Gilde
10% owner
Aug 5, 2026Sale−7,338$22.64$166.13K2,214,302
Healthcare Holding B.V. Gilde
10% owner
Aug 4, 2026Sale−99,812$22.77$2.27M2,221,640
Healthcare Holding B.V. Gilde
10% owner
Aug 3, 2026Sale−10,751$22.71$244.16K2,321,452
Healthcare Holding B.V. Gilde
10% owner
Jul 31, 2026Sale−20,034$22.73$455.37K2,332,203
Healthcare Holding B.V. Gilde
10% owner
Jul 30, 2026Sale−28,245$23.36$659.80K2,352,237
Richard Buchholz
Director
Jun 26, 2026Award+5,046––18,712
Kevin K. Sidow
Director
Jun 26, 2026Award+5,046––25,056
Andrew Hykes
Director
Jun 26, 2026Award+5,046––6,769
Casey M. Tansey
Director, 10% owner
Jun 26, 2026Award+5,046––52,712
Paul Buckman
Director
Jun 26, 2026Award+5,046––63,750
Matthew Fraser Ahearn
Chief Operating Officer, Director
Jun 15, 2026Sale(10b5-1 plan)−2,500$19.26$48.15K269,176
Matthew Fraser Ahearn
Chief Operating Officer, Director
Jun 15, 2026Sale(10b5-1 plan)−1,644$18.20$29.92K271,676
Matthew Fraser Ahearn
Chief Operating Officer, Director
Jun 12, 2026Sale(10b5-1 plan)−15,856$18.68$296.19K273,320
Robert Joseph Ball
CEO & Executive Chairman, Director
Apr 30, 2026Option exercise+10,000$2.48$24.80K300,018
Matthew Fraser Ahearn
Chief Operating Officer, Director
Apr 20, 2026Option exercise+14,243$2.86$40.73K286,765
Matthew Fraser Ahearn
Chief Operating Officer, Director
Apr 20, 2026Option exercise+7,421$2.48$18.40K272,522
Paul Buckman
Director
Mar 13, 2026Option exercise+26,205$2.10$55.03K65,710
Paul Buckman
Director
Mar 13, 2026Option exercise+19,401$2.48$48.11K39,505
Paul Buckman
Director
Mar 13, 2026Tax withholding−3,292$14.62$48.13K62,418
Paul Buckman
Director
Mar 13, 2026Tax withholding−3,714$14.82$55.04K58,704
Robert Joseph Ball
CEO & Executive Chairman, Director
Mar 13, 2026Buy+2,200$15.18$33.40K278,866
Jeffrey S. Points
Chief Financial Officer
Mar 13, 2026Option exercise+13,264$2.48$32.89K68,785
Jeffrey S. Points
Chief Financial Officer
Mar 13, 2026Buy+2,000$15.00$30.00K70,785
Richard Buchholz
Director
Mar 13, 2026Buy+1,000$14.84$14.84K13,666
Robert Joseph Ball
CEO & Executive Chairman, Director
Feb 6, 2026Option exercise+10,000$2.48$24.80K274,604
Robert Joseph Ball
CEO & Executive Chairman, Director
Feb 6, 2026Option exercise+2,062$2.10$4.33K276,666
Matthew Fraser Ahearn
Chief Operating Officer, Director
Dec 31, 2025Award+477$12.16$5.80K215,856
David Lawrence Blue
See Remarks
Dec 31, 2025Award+1,041$12.16$12.66K139,372
Jeffrey S. Points
Chief Financial Officer
Dec 31, 2025Award+1,076$12.16$13.08K55,521
Robert Joseph Ball
CEO & Executive Chairman, Director
Dec 31, 2025Award+1,661$12.16$20.20K120,118
Robert Joseph Ball
CEO & Executive Chairman, Director
Dec 12, 2025Buy+3,900$14.89$58.07K118,457
Jeffrey S. Points
Chief Financial Officer
Dec 12, 2025Buy+1,005$14.98$15.05K54,445
Robert Joseph Ball
CEO & Executive Chairman, Director
Dec 11, 2025Buy+3,300$14.83$48.94K114,557
Jeffrey S. Points
Chief Financial Officer
Dec 11, 2025Buy+995$14.65$14.58K53,440
Robert Joseph Ball
CEO & EXECUTIVE CHAIRMAN, Director
Sep 12, 2025Buy+6,000$15.49$92.94K111,259
Jeffrey S. Points
CHIEF FINANCIAL OFFICER
Sep 12, 2025Buy+1,600$15.67$25.07K52,445
David Lawrence Blue
SEE REMARKS
Sep 12, 2025Option exercise+78,616$2.10$165.09K122,553
David Lawrence Blue
SEE REMARKS
Sep 12, 2025Option exercise+15,778$2.48$39.13K138,331
Robert Joseph Ball
CEO & EXECUTIVE CHAIRMAN, Director
Sep 11, 2025Buy+2,000$14.90$29.80K105,259
Jeffrey S. Points
CHIEF FINANCIAL OFFICER
Sep 11, 2025Option exercise+13,264$2.48$32.89K50,845
Matthew Fraser Ahearn
CHIEF OPERATING OFFICER, Director
Sep 11, 2025Option exercise+12,286$0.93$11.43K120,320
Matthew Fraser Ahearn
CHIEF OPERATING OFFICER, Director
Sep 11, 2025Option exercise+16,443$2.48$40.78K215,379
Matthew Fraser Ahearn
CHIEF OPERATING OFFICER, Director
Sep 11, 2025Option exercise+78,616$2.10$165.09K198,936

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
5.65%
1M shares short
Days to cover
7.7
At 0M shares a day
Change since last report
-0.5%
From 1M shares
Short volume, 20 days
44.4%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Shoulder Innovations's stock actually held short. Settlement fails (shares not delivered on time) peaked at 4,339 shares on Sep 29, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Robert Joseph Ball
Officer, Director
Sep 14, 202610,175$187.71KSep 14, 2026Private Acquisition from Issuer/Affiliate
Matthew Fraser Ahearn
Director, Officer
Aug 17, 202622,500$466.43KAug 17, 2026Preferred Equity Financing
Gilde Healthcare Holding B.V.; Cooperatieve Gilde Healthcare V U.A.
10% Stockholder
Jul 29, 2026200,000$4.85MJul 29, 2026Private placement of Series D convertible preferred stock; converted into common stock upon IPO closing 08/01/2025. Holding period tacks under Rule 144(d)(3)(ii).
Matthew Fraser Ahearn
Director, Officer
Jun 12, 202620,000$375.20KJun 12, 2026Preferred Equity Financing

Congress trades

2 trades in Shoulder Innovations reported by 1 member of the House

MemberTypeTradedAmountFiled
Christopher L. Jacobs
NY27
SoldNov 8, 2022$1K–15KDec 12, 2022
Christopher L. Jacobs
NY27
BoughtJul 18, 2022$1K–15KSep 9, 2022
53 days late

See a number that looks wrong?